KRAS Biomarkers News and reporting on KRAS biomarkers. Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan Amoy Diagnostics will develop its PCR-based panel as a companion diagnostic in Japan to screen NSCLC patients for Amgen's KRAS G12C inhibitor. FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC. Qiagen, Mirati Therapeutics Partner to Develop KRAS Companion Test for NSCLC Drug The tissue-based test will identify cancer patients who may benefit from adagrasib, Mirati's investigational oral small molecule inhibitor of KRAS G12C. Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC As part of its Biomarker Assist program, Amgen will cover the cost of NeoGenomics' KRAS tests for advanced or metastatic NSCLC patients regardless of their insurance status. Strata, Mirati Therapeutics Partner on Tumor-Agnostic Clinical Trial of Novel KRAS G12C Inhibitor Strata will use its StrataNGS profiling test to identify patients with advanced solid tumors harboring KRAS G12C mutations for enrollment into Mirati's KRYSTAL-1 trial. Apr 27, 2020 Amid COVID-19, Lower Cancer Diagnosis Rates Mean Fewer Patients Getting Molecular Tests, Treatment Premium Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Jan 27, 2020 Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers Premium Jan 14, 2020 Qiagen, Amgen Collaborate to Develop CDx for Investigational NSCLC Drug Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Aug 2, 2019 Comparison of KRAS Liquid Biopsy Kits Confirms Differences at Low Mutant Allele Fraction Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium May 29, 2019 CRISPR Framework Helps Identify Combination Therapies for Optimal Targeting of KRAS Mutant Feb 26, 2019 Thermo Fisher Scientific Oncomine Dx Target Test Gets Expanded Regulatory Approval in Japan Jan 29, 2019 AmoyDx, Sanomics Ink Deal for Multigene Mutation Detection Kit Oct 31, 2018 Lung Cancer Panel From PlexBio Receives CE Mark Oct 17, 2018 Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test Sep 27, 2018 UK Group Develops Cancer Liquid Biopsy Assay to Detect Low-Level Mutations Premium Oct 17, 2017 AstraZeneca Publishes Head-to-Head Study of 13 KRAS Mutation Detection Technologies Premium Jan 6, 2017 Two Pore Guys Collaborating With UCSF on Point-of-Care Liquid Biopsy Dec 15, 2016 Biocartis Gets CE Mark for Idylla NRAS-BRAF Mutation Test Oct 3, 2016 KRAS-Driven Tumor Growth Inhibited by MicroRNA May 13, 2016 Colorectal Cancer Patients' Cetuximab Response Can Be Discerned From FCGR2A Genotype Premium Oct 27, 2015 Biocartis Granted $1.5M to Develop Liquid Biopsy Version of KRAS, BRAF Tests Jul 9, 2015 U of Toronto Study Demos Electrochemical Clamp Chip for Detection of Circulating Nucleic Acids Premium Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.